SummaryRMgm-676
|
Successful modification | The parasite was generated by the genetic modification |
The mutant contains the following genetic modification(s) | Gene tagging |
Reference (PubMed-PMID number) |
Reference 1 (PMID number) : 22139844 |
MR4 number | |
top of page | |
Parent parasite used to introduce the genetic modification | |
Rodent Malaria Parasite | P. berghei |
Parent strain/line | P. berghei ANKA |
Name parent line/clone | Not applicable |
Other information parent line | |
top of page | |
The mutant parasite was generated by | |
Name PI/Researcher | Montagna, G.N.; Matuschewski, K. |
Name Group/Department | Parasitology Unit |
Name Institute | Max Planck Institute for Infection Biology |
City | Berlin |
Country | Germany |
top of page | |
Name of the mutant parasite | |
RMgm number | RMgm-676 |
Principal name | HSP20-mCherry |
Alternative name | |
Standardized name | |
Is the mutant parasite cloned after genetic modification | Yes |
top of page | |
Phenotype | |
Asexual blood stage | mCherry signals barely detected in all blood stages |
Gametocyte/Gamete | Not different from wild type |
Fertilization and ookinete | mCherry-HSP20 abundantly expressed in ookinetes |
Oocyst | mCherry-HSP20 abundantly expressed in oocysts |
Sporozoite | mCherry-HSP20 abundantly expressed in sporozoites (see 'Additional remarks phenotype') |
Liver stage | See 'Additional remarks phenotype' |
Additional remarks phenotype | Mutant/mutation Phenotype analyses of mutants lacking expression of HSP20 (RMgm-672, RMgm-675) provide evidence that HSP20 is involved in ookinete and sporozoite motility. Phenotype Additional information |
top of page | |||||||||||||||||||||||||||
Details of the target gene | |||||||||||||||||||||||||||
Gene Model of Rodent Parasite | PBANKA_0714300 | ||||||||||||||||||||||||||
Gene Model P. falciparum ortholog | PF3D7_0816500 | ||||||||||||||||||||||||||
Gene product | small heat shock protein HSP20, putative | ||||||||||||||||||||||||||
Gene product: Alternative name | HSP20 | ||||||||||||||||||||||||||
top of page | |||||||||||||||||||||||||||
Details of the genetic modification | |||||||||||||||||||||||||||
Name of the tag | mCherry | ||||||||||||||||||||||||||
Details of tagging | C-terminal | ||||||||||||||||||||||||||
Additional remarks: tagging | |||||||||||||||||||||||||||
Commercial source of tag-antibodies | |||||||||||||||||||||||||||
Type of plasmid/construct | Plasmid single cross-over | ||||||||||||||||||||||||||
PlasmoGEM (Sanger) construct/vector used | No | ||||||||||||||||||||||||||
Modified PlasmoGEM construct/vector used | No | ||||||||||||||||||||||||||
Plasmid/construct map | |||||||||||||||||||||||||||
Plasmid/construct sequence | |||||||||||||||||||||||||||
Restriction sites to linearize plasmid | PacI | ||||||||||||||||||||||||||
Selectable marker used to select the mutant parasite | tgdhfr | ||||||||||||||||||||||||||
Promoter of the selectable marker | pbdhfr | ||||||||||||||||||||||||||
Selection (positive) procedure | pyrimethamine | ||||||||||||||||||||||||||
Selection (negative) procedure | No | ||||||||||||||||||||||||||
Additional remarks genetic modification | For fusion of the red fluorescent protein mCherry to the PbHSP20 5’UTR and ORF, a 1493 bp fragment was cloned into SacII-SpeI sites of the BD3+mCherry vector. A PCR fragment corresponding to the PbHSP20 5’UTR and ORF was amplified with primers 5’UTR Hsp20 SacII (5´-TCCCCGCGGGGAGTTTAAAATTATTGCTAGTTC-3´) and Hsp20 rvSpeI (5’- CGGACTAGTCCGTGCTTCGTTTATTTCTACTTTATGC-3’) and cloned into the SacII-SpeI sites of the BD3D+mCherry vector, resulting in the HSP20 mCherry fusion construct. This targeting plasmid was linearized with PacI. | ||||||||||||||||||||||||||
Additional remarks selection procedure | |||||||||||||||||||||||||||
| |||||||||||||||||||||||||||
top of page |